Immunoproteomics technologies in the discovery of autoantigens in autoimmune diseases
Proteomics technologies are often used for the identification of protein targets of the immune system. Here, we discuss the immunoproteomics technologies used for the discovery of autoantigens in autoimmune diseases where immune system dysregulation plays a central role in disease onset and progress...
Main Authors: | Ganesan Vinitha, Ascherman Dana P., Minden Jonathan S. |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2016-05-01
|
Series: | Biomolecular Concepts |
Subjects: | |
Online Access: | https://doi.org/10.1515/bmc-2016-0007 |
Similar Items
-
Autoantigens in the trabecular meshwork and glaucoma‐specific alterations in the natural autoantibody repertoire
by: Vanessa M Beutgen, et al.
Published: (2020-01-01) -
Exploring the Immunoproteome for Ovarian Cancer Biomarker Discovery
by: Martin K. Oehler, et al.
Published: (2011-01-01) -
A comprehensive autoantigen-ome of autoimmune liver diseases identified from dermatan sulfate affinity enrichment of liver tissue proteins
by: Wei Zhang, et al.
Published: (2019-06-01) -
DFS70/LEDGFp75: an enigmatic autoantigen at the interface between autoimmunity, AIDS, and cancer
by: Anamika eBasu, et al.
Published: (2015-03-01) -
Autoantibodies Targeting Intracellular and Extracellular Proteins in Autoimmunity
by: Peter D. Burbelo, et al.
Published: (2021-03-01)